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Paracrine signalingPlasmamembrane hemichannels composed of connexin (Cx) proteins are essential components of gap junction
channels but accumulating evidence suggests functions of hemichannels beyond the communication provided
by junctional channels. Hemichannels not incorporated into gap junctions, called unapposed hemichannels,
can open in response to a variety of signals, electrical and chemical, thereby forming a conduit between the cell's
interior and the extracellular milieu. Open hemichannels allow the bidirectional passage of ions and small met-
abolic or signaling molecules of below 1–2 kDa molecular weight. In addition to connexins, hemichannels can
also be formed by pannexin (Panx) proteins and current evidence suggests that Cx26, Cx32, Cx36, Cx43 and
Panx1, form hemichannels that allow the diffusive release of paracrine messengers. In particular, the case is
strong for ATP but substantial evidence is also available for other messengers like glutamate and
prostaglandins or metabolic substances like NAD+ or glutathione. While this ﬁeld is clearly in expansion,
evidence is still lacking at essential points of the paracrine signaling cascade that includes not only messenger
release, but also downstream receptor signaling and consequent functional effects. The data available at this
moment largely derives from in vitro experiments and still suffers from the difﬁculty of separating the functions
of connexin-based hemichannels from gap junctions and from pannexin hemichannels. However, messengers
like ATP or glutamate have universal roles in the body and further deﬁning the contribution of hemichannels
as a possible release pathway is expected to open novel avenues for better understanding their contribution to
a variety of physiological and pathological processes. This article is part of a Special Issue entitled: The Commu-
nicating junctions, roles and dysfunctions.
© 2012 Elsevier B.V. All rights reserved.Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2. Triggers for hemichannel opening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.1. Transmembrane voltage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2. Extracellular and intracellular ions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.3. Mechanical strain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.4. Post-translational modiﬁcations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.5. Triggers and modulation of pannexin-based hemichannels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3. Methodological approaches for studying hemichannels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.1. Biochemical identiﬁcation of unapposed plasma membrane hemichannels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.2. Electrophysiology of unapposed hemichannels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.3. Uptake or release of reporter molecules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.4. Interfering with hemichannel function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40e Communicating junctions, roles and dysfunctions.
k B, Rm. 031), B-9000 Ghent, Belgium. Tel.: +32 9 332 33 66; fax: +32 9 332 30 59.
ert).
rights reserved.
36 N. Wang et al. / Biochimica et Biophysica Acta 1828 (2013) 35–504. Signaling molecules released through hemichannels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.1. ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.1.1. ATP release in the context of intercellular calcium waves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.1.2. ATP release in the cochlea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
4.1.3. ATP release in taste transduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
4.1.4. ATP release inﬂuencing cell death/cell survival in disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.1.5. ATP and immune cell responses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.1.6. ATP and immune effects of pannexin hemichannels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.2. NAD+ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.3. Glutamate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.4. Glutathione . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
4.5. Prostaglandin E2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
5. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
Acknowledgement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 471. Introduction
In multicellular systems, proper organ and tissue function is
sustained by cell-to-cell signal transduction that coordinates cell
function by intercellular communication. This cross-talk between
cells can be achieved in a direct manner, by the transfer of signaling
molecules through gap junction channels that are composed of
connexin proteins [1]. The latter consists of four membrane-
spanning domains, two extracellular loops, an intracellular loop and
ﬂanking N- and C-termini also located on the intracellular side. AtTable 1











PGE2: prostaglandin E2. EET: epoxyeicosatrienoic acids.present, 20 connexin genes have been identiﬁed in the mouse and
21 in the human genome [2]. Newly synthesized connexins are
oligomerized in the Golgi apparatus and the trans-Golgi network to
hexameric channels called hemichannels [3]. Following insertion
into the plasma membrane, connexin hemichannels interact with
their counterparts on neighboring cells in a head-to-head arrange-
ment, forming gap junction channels that coalesce into junctional
plaques. Gap junctions allow the direct exchange between cells of
metabolic and signaling molecules with molecular weight (MW)
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open, unapposed hemichannels form a transmembrane conduit,
allowing the passage of ions and molecules with a similar size
cut-off limit as for gap junction channels. Table 1 gives an overview
of the substances for which there is evidence that they may be
released via connexin hemichannels. Cytosolic signaling molecules
including adenosine triphosphate (ATP), nicotinamide adenine
dinucleotide (NAD+), glutamate, glutathione and prostaglandins
thus can diffuse through the channel to reach the extracellular mi-
lieu, mediating the spread of the signal followed by binding to re-
ceptors on surrounding cells and activating downstream cellular
responses. Here, we review the available evidence for connexin
hemichannels as a release pathway for paracrine intercellular com-
munication and their role in paracrine signaling under normal and
pathological conditions. First, we summarize the factors and condi-
tions leading to connexin hemichannel opening and the methods
used to study their function. We then give an overview of paracrine
messengers released via hemichannels and discuss their possible
contribution to tissue/organ function. In addition, we discuss
pannexin (Panx) hemichannels as a release pathway for paracrine
messengers (see also Table 1). Panx proteins are orthologues of in-
vertebrate innexins and currently consist of 3 members: Panx1,
Panx2 and Panx3 [5]. They do not share a sequence homology with
connexins but have a similar structure and membrane topology
[6]. Pannexins are considered to predominantly form unapposed
hemichannels and not gap junctions [7,8], and for this reason it
has been proposed to call pannexin hemichannels just ‘channels’
[7]. We prefer to call pannexin-based channels ‘hemichannels’
until it is mechanistically clear why these proteins cannot form
gap junction channels. This is also beneﬁcial in terms of clarity, as
the two hemichannel types – composed of pannexins or connexins
– form a special class of release channels for paracrine messengers.
2. Triggers for hemichannel opening
2.1. Transmembrane voltage
Connexin hemichannels are present as unapposed channels in
the plasma membrane, on their way to being incorporated into gap
junctions. Unapposed hemichannels are typically closed under nor-
mal conditions and, based on the large unitary conductance of
hemichannels composed of certain connexins like Cx26, Cx43 and
Cx46 (200–350 pS), they have long been assumed to remain closed
until forming gap junctions, to prevent the loss of essential small
molecules and the dissipation of ion gradients for Ca2+, Na+ and
K+. In the early 90s the ﬁrst reports appeared suggesting that
unapposed hemichannels may open under certain conditions. The
opening of unapposed connexin hemichannels in the plasma mem-
brane was initially reported in Xenopus oocytes exogenously ex-
pressing lens ﬁber Cx46 [9,10]. Although the ﬁnding was originally
thought to be restricted to the oocyte expression system, later evi-
dence brought up the possibility that Cx46 can also form unapposed
hemichannels in the lens [11,12]. Up to date, a wide range of
connexin types have been reported to form unapposed plasmamem-
brane hemichannels that can be opened by certain stimuli. Electro-
physiological evidence documenting hemichannel opening is now
available for Cx26, Cx30, Cx31.9, Cx30.2, Cx32, Cx35, Cx36, Cx37,
Cx38, Cx43, Cx45, Cx45.6, Cx46, Cx50, Cx55.5 and Cx56 [13–23]. Sim-
ilar to voltage-sensitive ion channels, connexin hemichannels (ex-
cept Cx36 and Cx30.2) are sensitive to transmembrane voltage
(Vm). Membrane polarization to positive potentials tends to open
hemichannels composed of Cx26, Cx30, Cx32, Cx35, Cx37, Cx43,
Cx45 and Cx46 (reviewed in [24]). By contrast, Cx50 hemichannels
remain open over a wide voltage range and only close when Vm is
below −50 mV or above +20 mV [13]. In line with the voltage-
dependent proﬁle of hemichannel opening, changes of Vm broughtabout by oxidative stress have been reported to activate connexin
hemichannels [25].
2.2. Extracellular and intracellular ions
Opening of unapposed hemichannels is potentiated by lowering the
extracellular calcium concentration ([Ca2+]o; normal level 1–2 mM)
[26], a condition that often is associated with organ ischemia [27].
Atomic force microscopy (AFM) of reconstituted Cx43 and Cx40
hemichannels have detailed real-time transitions between closed and
open conformations as a function of [Ca2+]o [28,29]. Similar changes
of channel structure by external Ca2+ including the conﬁned extracellu-
lar vestibule of the lumen was also reported in Cx26 hemichannels
dissected from gap junctions making use of the AFM stylus [30]. The
initial explanation was that Ca2+ ions attracted by the negative resting
Vm enter the channel pore and bind to a channel blocking site at the
cytoplasmic end [18]. A later study on Cx46 hemichannels however
argued that [Ca2+]o may modulate intrinsic voltage-dependent gating
by binding to an extracellular side of the hemichannel, locking the chan-
nel to a long-lived closed state [31]. In Cx32 hemichannels, a ring of 12
Asp residues residing at the external vestibule of the channel pore has
been identiﬁed as a Ca2+-binding site that accounts for the channel
block [23]. Interestingly, replacing external Na+ with other monovalent
cations such as K+ or Cs+ can reduce Cx50 hemichannel sensitivity to
[Ca2+]o [32]. Removal of extracellular Cl− has been reported to potenti-
ate the opening of Cx43 hemichannels as concluded from ATP release
measurements [33]. While low [Ca2+]o increases the open probability
of hemichannels, changes in intracellular Ca2+ concentration ([Ca2+]i)
also affect the function of hemichannels. Hemichannels formed of
Cx32 or Cx43 exhibit enhanced ATP release and dye uptake in response
to a moderate elevation of [Ca2+]i to ~500 nM [34,35]. Hemichannel
opening triggered by [Ca2+]i changes has been reported in embryonic
retinal pigment epithelium, in neural precursor cells and in supporting
cells of the organ of Corti in the inner ear [36–38]. So far reported data
show that hemichannel opening requires an intramolecular binding of
C-terminal domain (CT) to cytoplasmic loop (CL) [39], possibly acting
via an intermediate signaling pathway including Ca2+/Calmodulin
(CaM), Ca2+/CaM-dependent protein kinase II and p38 mitogen-
activated protein kinase (MAPK) [35,40]. Cx43 hemichannels are also
equipped with inactivation mechanisms and channel closure has been
reported to occur when [Ca2+]i rises above 500 nM [34,35]. Recent
work has conﬁrmed this inhibition by high [Ca2+]i at the unitary current
level (Wang et al., under review).
2.3. Mechanical strain
Mechanical forces acting on the plasma membrane or on the
connexin protein also mediate hemichannel opening. This was ﬁrst
demonstrated in Cx46-expressing Xenopus oocytes exposed to a nega-
tive pressure or hypotonic solution,which caused hemichannel opening
at negative holding potential [41]. Further studies pointed out that
many other connexins exhibit a similar mechanosensitivity. In tissues
normally exposed to mechanical stress, such as osteocytes, periodontal
ligaments and corneal endothelial cells, Cx43 hemichannels tend to
open in response to mechanical stimulation and mediate the release
of ATP or prostaglandin E2 [42–44]. These extracellular signaling mole-
cules, aswill be discussed later, are proposed to play a role in controlling
tissue formation and regeneration. Activation of hemichannels by
mechanical forces has also been reported in astrocytes expressing
Cx43, cochlear cells expressing Cx26 as well as hepatocytes expressing
Cx26 and Cx32 [45–47]. It is still not clearwhichmolecularmechanisms
underlie mechanical stress-related activation of connexin hemichannels.
Cx43 hemichannels do not appear to respond directly to mechanical
strain; in osteocytes, mechanical signals are transduced via the glycocalyx
network, leading to rearrangement of actin cytoskeleton and Cx43
hemichannel opening [48]. The fact that stress-induced ATP release
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may also act via [Ca2+]i elevation [43]. In primary osteocytes, shear stress
increased the fraction of plasmamembrane-associated Cx43 protein rela-
tive to the total connexin expression, suggesting that augmented activi-
ties of hemichannels are related to their enhanced presence in the
plasma membrane [49].
2.4. Post-translational modiﬁcations
Many connexins (except Cx26) are phosphoproteins and collected
data show that alterations in their phosphorylation status clearly affect
functions of connexin hemichannels. In Xenopus oocytes exogenously
expressing Cx46, protein kinase C (PKC) directly phosphorylates Cx46,
resulting in reduced Cx46 hemichannel-mediated currents [50,51].
Similarly, reconstituted Cx43 hemichannels in liposomes exhibited
reduced permeability in response to PKC-mediated phosphorylation
of serine 368 [52]. Channels containing the serine 368 substitution
to alanine are resistant to PKC modulation and stay preferentially
open, suggesting that dephosphorylation of serine 368 favors Cx43
hemichannels opening [52,53]. A MAPK phosphorylation site has also
been identiﬁed in Cx43, which causes reduced hemichannel function
upon phosphorylation. Hyperosmolarity-induced activation of Cx43
hemichannels may be attributed to dephosphorylation at PKC or
MAPK consensus site [54]. Intracellular ATP depletion in renal-tubule
cells causes dephosphorylation at serine 368 which enhances Cx43
hemichannel activities [55]. The additional post-translational modiﬁca-
tion of S-nitrosylation of Cx43 CT domains also inﬂuenced hemichannel
activity and the net effect of suchmodiﬁcation appears to dependon the
phosphorylation state of the connexin protein [24,56,57].
2.5. Triggers and modulation of pannexin-based hemichannels
Among the pannexins, Panx1 has been best documented in terms
of its hemichannel function as a passageway for ions, metabolites and
signaling molecules with a MW below 1 kDa, for example ATP [58].
Extensive electrophysiological data demonstrate Panx1 hemichannel
opening upon membrane depolarization (see next section). Thus far,
there is no evidence that Panx2 forms functional (homomeric)
hemichannels, but Panx2 may be involved, together with Panx1, in
heteromeric hemichannels [59,60]. Little evidence is yet available
concerning Panx3 hemichannels; recentwork in osteoblasts anticipates
the presence of Panx3 hemichannels both in endoplasmic reticulumFig. 1. P2X7 receptors are essential to confer sensitivity to extracellular Ca2+ of Panx1 hem
Panx1 hemichannels both favor the closed states and no interaction takes place between the
the binding afﬁnity (Kd lowering) of the channel for endogenously released ATP. Activation
turn serve as an associated portal, allowing the passage of ATP or reporter dyes with a MW b
and Panx1 hemichannel further by an undeﬁned signaling mechanism, yet independent on
dized ATP and Panx1 hemichannel blockers carbenoxolone abolish the low [Ca2+]o-triggerand cell surface [61]. Mechanical plasma membrane stress activates
Panx1 hemichannels exogenously expressed in Xenopus oocytes
[62,63]. An increased extracellular K+ concentration caused by exces-
sive neuronal activity has been reported to stimulate astrocytic Panx1
hemichannels also in a membrane potential-independent manner
[64], by an intrinsic yet undeﬁned effect of extracellular K+. Panx1
hemichannels are also activated by purinergic stimulation: when
expressed in Xenopus oocytes, they open in response to activation of
P2Y receptors [62]. In addition, there is strong evidence that Panx1
hemichannels are the large conductance pore recruited in response to
prolonged activation of P2X7 receptors [65]. Thus, P2X7 receptors may
act in concert with Panx1 hemichannel as a mechanism of ATP-
induced ATP release. Panx1 hemichannels do not respond to changes
of [Ca2+]o [66]. However, in cells co-expressing P2X7 receptors and
Panx1, removal of extracellular Ca2+may open the channel via indirect
mechanisms including i) a promoted complex formation between P2X7
receptors and Panx1 hemichannels, and ii) an enhanced afﬁnity of P2X7
receptors to such an extent that baseline ATP release (regardless of the
mechanisms involved) is sufﬁcient for Panx1 channel activation [67]
(Fig. 1).
Like hemichannels composed of Cx32 and Cx43, Panx1 hemichan-
nels are also equipped with an inactivation mechanism, with channel
closure occurring as a consequence of ATP-induced inhibitory feed-
back [68]. Although Panx1 and Panx3 both possess several putative
phosphorylation sites at the intracellular domains, treatment of alka-
line phosphoatase failed to alter any shifts in electrophoretic mobility
of the proteins [8]. Instead, Panx1 and Panx3 are glycosylated at the
second and ﬁrst extracellular loop regions, respectively [8,69]. The
impact of glycosylation on pannexin hemichannel functions remains
unclear, but this post-translational modiﬁcation distinct from con-
nexins is crucial for intracellular trafﬁcking and is thought to explain
the unlikelihood of docking between two pannexin hemichannels
[69–71]. Finally, Panx1 is a substrate of caspase [72]: during apoptosis,
caspase-mediated cleavage at the CT domain promotes hemichannel
activity.
3. Methodological approaches for studying hemichannels
Before discussing the role of hemichannels as a release pathway
for paracrine messengers, it is important to summarize the methods
and tools used to study function of hemichannels. Most importantly,
not all approaches when used individually lead to equally strongichannels. A. At normal extracellular Ca2+ concentration ([Ca2+]o), P2X7 receptors and
se two channels. B. Removal of extracellular Ca2+ activates P2X7 receptor by increasing
of the P2X7 receptor initiates complex formation with Panx1 hemichannels which in
elow ~1 kDa. Lowering [Ca2+]o may strengthen the interaction between P2X7 receptor
purinergic stimulation. Both P2X7 receptor inhibitors such as Brilliant blue G and oxi-
ed ATP release.
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terpretation of experimental data [73].
3.1. Biochemical identiﬁcation of unapposed plasma
membrane hemichannels
In the early 1990sMusil and Goodenough introduced a biotinylation
technique for the isolation of unapposed hemichannels in the plasma
membrane [74]. The technique is based on the labeling of free surface
membrane protein containing lysine residues in intact cells, making
use of the membrane-impermeable and thiol-cleavable amine-
reactive reagent NHS-SS-Biotin. In gap junction channels, the reactive
lysine residues at the extracellular side of the connexin protein are
sealed into the intercellular space and therefore inaccessible for the bi-
otin assay [75]. Thus, only unapposed hemichannels at non-junctional
membranes are labeled by biotin. Further processing by pull down of
avidin–biotin–connexin complexes and subsequent separation of
connexin from this complex via elution column allow enrichment of
the connexin pool associated with unapposed hemichannels. Further
work has validated this method for evaluating the role of Cx43 and
Cx32 hemichannels in non-junctional membranes [40,49,56,57,76–78].
Biochemical isolation of Triton X-100 (a non-ionic detergent)
insoluble fraction [74] is a widely pursued alternative for isolating
connexins assembled into gap junction channels. However, the
detergent-resistant fraction may be contaminated by hemichannels.
Connexin hemichannels are located in ‘lipid rafts’, which are mem-
brane microdomains enriched in sphingolipids and cholesterol [79].
Close lipid packing at these regions limits the accessibility of con-
nexin hemichannels to the detergent which thus should be consid-
ered as detergent-resistant. Gap junction plaques do not colocalize
with lipid raft structures [79,80] but may also be associated with
high cholesterol membrane zones.
Microscopic imaging provides the most direct approach towards
identifying unapposed plasma membrane hemichannels. Among the
membrane fractions isolated from rat heart, atomic force microscopy
characterized a population of native connexin channels that shares sim-
ilar hexameric arrangement as gap junctions, but has half the thickness
of a gap junction channel. These structures described by Lal et al. as
‘hemiplaques’, should be considered as the earliest evidence addressing
structural aspects of unapposed hemichannels at the cell surface [81]. In
intact cells or tissue, differentiating hemichannels at the non-junctional
side of the membrane from whole junctions is based on antibodies di-
rected against conserved sequences of the ﬁrst or second extracellular
loop of the connexin protein; such antibodies are available for Cx26,
Cx32 and Cx43 [82,83]. These site-directed antibodies only recognize
freely-exposed extracellular loops of the connexins in the plasmamem-
brane, thus speciﬁcally reporting the surface distribution of unapposed
hemichannels.
3.2. Electrophysiology of unapposed hemichannels
The most direct approach to study functions of connexin
hemichannels is by means of electrophysiological recording of unitary
currents. The single channel conductance is the signature of connexin
isoform being recorded from. The voltage–conductance proﬁle further-
more helps in identifying the hemichannel type [84]. In whole-cell re-
cordings on single non-connected HeLa cells overexpressing Cx43,
unitary events associated with Cx43 hemichannel openings can be un-
ambiguously recognized by the single channel conductance (γo) of
~220 pS when stepping the Vm to positive potentials (>+40 mV)
[15] (Fig. 2). In astrocytes exposed to pro-inﬂammatory cytokines,
these typical ~220 pS single-channel events appeared at negative Vm,
indicating that increased channel opening can also be induced at nor-
mal resting potentials [78]. Cx43 hemichannel current reverses near
0 mV, indicating a non-selective nature of the channel. For Cx26 and
Cx46 hemichannels characterized in Xenopus oocytes, a moderatedepolarization from−80 to−50 mV appears to be sufﬁcient to trigger
single channel openings with a γo of ~317 pS and ~300 pS, respectively
[16,85]. Hemichannels composed of Panx1 exhibit substantially larger
unitary conductance of ~475 pS as reported in Xenopus oocytes and
~520 pS in pyramidal neurons [63,86]. Macroscopic current recordings
reported a low voltage threshold for Panx1 hemichannel activation
(~−20 mV) [66].
It remains uncertain why different connexins exhibit distinct
voltage-sensitivities and a broad range of unitary conductances. Mul-
tiple domains including N-terminus, the ﬁrst transmembrane domain
and the ﬁrst extracellular loop have all been implicated in pore-lining
of connexin hemichannels [87–90]. Mutagenesis at these sites is asso-
ciated with modiﬁed charge selectivity and unitary conductance. Di-
verse unitary conductances are not unexpected given the fact that
pore-lining segments may differ across connexins. Moreover, there
is no deﬁnitive answer yet to where the voltage sensor of a connexin
hemichannel is located. It seems that voltage-sensing domain reﬂects
another connexin-speciﬁc property [91–93]. Therefore, further stud-
ies are needed to ascribe connexin type-dependent differences to in-
trinsic properties of the hemichannel building blocks. Noteworthy,
the biophysical properties of hemichannels also depend on species-
speciﬁc differences of the same connexin isoform and on expression
system in which the hemichannels are examined. For example, Cx43
hemichannels do not open in response to depolarization when
expressed in Xenopus oocytes [94] but they do open in mammalian
cells endogenously or exogenously expressing Cx43. Xenopus oocytes
overexpressing Panx1 exhibit a prominent increase of hemichannel
currents by elevating [Ca2+]i [62] but these results cannot be
reproduced in mammalian cells stably transfected with Panx1 [95]
or in hippocampal neurons [96]. In terms of species-speciﬁc differ-
ences, it is known that human/sheep Cx26 but not rodent Cx26 are
capable of forming functional hemichannels as a consequence of dif-
ference in one amino acid [16].
3.3. Uptake or release of reporter molecules
Single channel recordings or biotinylation studies are not always
possible in intact tissues. In such cases, hemichannels can be studied
making use of the uptake into the cells of ﬂuorescent reporter dyes or
the release of endogenous or exogenously loaded molecules with a
MW below 1 kDa [9,97]. In connexin hemichannel studies, dye uptake
or release studies are performed using various low MW, membrane-
impermeable ﬂuorescent probes including Lucifer yellow (LY; MW=
444, net charge=−1), 6-carboxyﬂuorescein (CF; MW=376, net
charge=−2), calcein (MW=623, net charge=−4), ethidium bro-
mide (EtBr; MW=394, net charge=+1), DAPI (MW=279, net
charge=+2) and propidium iodide (PI; MW=668, net charge=+2)
[98,99]. YO-PRO-1 (MW 629, net charge=+2), similar as EtBr or PI,
with a dramatically increased ﬂuorescence intensity upon binding
to DNA and RNA are extensively used as an indicator for Panx1
hemichannel openings [65,72,100]. In both cultured and primary
cells, quantifying uptake or release of the intracellular ﬂuorescence
of reporter dye has been extensively pursued as an indirect measure
of connexin hemichannel activities [34,97,101,102,102,102,103].
Such experiments allow a dynamic assessment of hemichannel re-
sponse in real time using time-lapse imaging [104]. An advantage
of PI and EtBr as reporter dyes is that the ﬂuorescence of these probes
is strongly enhanced upon binding to DNA, increasing the contrast
and allowing more easy identiﬁcation of the cells displaying
hemichannel opening. Dye uptake assays are also suitable for
hemichannel characterization in intact in vitro tissues. EtBr uptake
studies have been applied to mouse hippocampal slices to study
hemichannel opening in astrocytes in response to exogenous glucose
deprivation [105]. In mice with bacterial infection-induced brain ab-
scess, a similar set of experiments was conducted to study the effect
of inﬂammation on astrocytic hemichannel openings [106]. In these
Fig. 2. Unitary current activities of Cx43 hemichannels. A. A schematic overview of whole cell recording in HeLa cells expressing Cx43 tagged with enhanced green ﬂuorescent pro-
tein (EGFP) at the C-terminal. Currents mediated by Cx43 hemichannels are recorded under conditions of blockade of K+ channels using tetra-ammonium chloride (TEACl), BaCl2
and CsCl. B. The ﬂuorescent image of Cx43-EGFP cells, illustrates abundant presence of Cx43 at the plasma membrane. C. Representative whole-cell currents recorded in the Hela
Cx43-EGFP cell indicated by an asterisk in panel B. Stepping Vm to +50 mV induces clearly discernible unitary current activities. The expanded trace shows tail currents with
step-wise closure of 3 channels upon Vm repolarization to −25 mV. D. All-point histogram of the conductance evaluated from the trace shown in C at +50 mV. The peaks of
the event distribution are separated by ~220 pS which equals to the γo of Cx43 hemichannels in the plasma membrane. E. Gently pulling the whole-cell recording electrode
away from the cell establishes an outside-out recording conﬁguration (extracellular face directed to the bath solution). F. Outside-out recordings often exhibit only a few active
hemichannels as illustrated in the example current trace. G. All-point histogram of the conductance evaluated from the currents shown in E indicates a γo of ~220 pS.
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pression under control of the glial ﬁbrillary acidic protein (GFAP)
promoter in transgenic animals. A major drawback of these assays
is that synthetic reporter dyes listed above are biologically irrelevant
[99]. This limitation may be overcome by using ﬂuorescently labeled
metabolic derivatives such as the ﬂuorescent glucose derivatives 2-[N-
(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG)
and the nonhydrolyzable 6-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)
amino]-6-deoxyglucose (6-NBDG) [78].
Open connexins and pannexin-based hemichannels also permit the
efﬂux of several bioactivemolecules such as ATP, glutamate and prosta-
glandin E2, which can be detected in the extracellular medium by
appropriate measurement techniques. A bioluminescence assay based
on luciferin–luciferase has been extensively used to detect extracellular
ATP, mainly because of its high sensitivity and linear response over a
very wide range of ATP concentrations. Because it has been used so
frequently, it suggests the false impression that hemichannels mainly
release ATP. Moreover, many other ATP release pathways exist such
as via the cystic ﬁbrosis transmembrane regulator (CFTR) protein,
volume- and voltage-dependent anion channels, voltage-gated Cl−
channels and P2X receptor pores. Work of the Nedergaard lab has
brought up an interesting approach that combined ATP release mea-
surements with single hemichannel recordings, to document in an un-
equivocal manner that hemichannels are indeed permeable to ATP
[107]. In this study, an inside-out patch excised from a glioma celloverexpressing Cx43 was subjected to single channel recording of
Cx43 hemichannels with ATP as main charge carrier. A second elec-
trode placed adjacent to the excised patch was used to expel small
quantities of luciferin/luciferase, allowing the detection of ATP pres-
ent in the extracellular milieu from the bioluminescent signal. A
close correlation between ATP release and unitary current activities
of Cx43 hemichannels provided ﬁrm evidence that connexin
hemichannels are involved in transmembrane ﬂux of ATP.
3.4. Interfering with hemichannel function
Suppression of speciﬁc connexin isoforms making use of small
interfering RNA technology or knock out (KO) animals are crucial to
help in elucidating the nature of the molecular uptake/release
pathway [99]. For example, an up to 60% Cx43 knockdown prevented
LY uptake in neuroblastoma (N2A) cell cultures and pointed to a
potential role of Cx43 hemichannels in oxidative-stress induced cell
death [25]. This can be complemented by connexin KO animal ap-
proaches, either as global KO, conditional KO in speciﬁc cell types or
inducible KO by tamoxifen injection (Cx43Cre-ER(T)/ﬂ, one Cx43 coding
region replaced by tamoxifen inducible Cre recombinase and the
other ﬂanked by two separate loxP sites) [108,109]. A critical limita-
tion of these genetic tools is that such approaches deplete both gap
junction channel and hemichannel populations, challenging the va-
lidity of the conclusions drawn from such experiments. In addition,
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in native cells and interfering with the expression of one connexin
can affect the expression of non-targeted connexin isoforms
[110–114]. Further work with more reﬁned models making use of in-
ducible knock in technology to switch on the expression of mutant
connexins that lack the extracellular loop cysteins and therefore are
unable to pair up as gap junctions may be an interesting approach
[101]. The use of highly selective hemichannel blockers is another
approach. However, gap junctions are composed of the very same
molecular building blocks and most gap junction blockers including
long-chain alcohols, glycyrrhetinic acid derivatives, and ﬂufenamic
acid also abrogate functions of unapposed hemichannels [115].
Some of these agents inﬂuence the membrane ﬂuidity and this
non-speciﬁc effect may have implications on other ion channels
present in the plasmamembrane. A recent study found that thewidely
used hemichannel blocker, carbenoxolone, can effectively block
volume-regulated anion channels [116]. Conversely, other ion channel
blockers like 5-nitro-2-(3-phenylpropyl-amino)-benzoic acid and
tamoxifen also inhibit hemichannel openings. Lanthanum (La3+,
100 μM) is a heavy metal ion that blocks depolarization-induced Cx43
hemichannel currents at the single channel [15] and macroscopic levels
aswell as calcein efﬂux in HeLa cells overexpressing Cx30-GFP [117], but
not Cx43 or Cx30 gap junctions [117,118]. It is hypothesized that La3+
interacts with a site on the extracellular loops of unapposed connexin
hemichannels which is freely accessible in the extracellular space, but
becomes tightly sealed into the cell–cell interface after docking [99].
Connexin mimetic peptides, like Gap26 and Gap27, that are iden-
tical to highly conserved sequences located respectively on the ﬁrst
and second extracellular loop regions of for example Cx32, Cx37
and Cx43 are known as gap junction blockers. They were introduced
in the 90s based on the hypothesis that such peptides could prevent
docking of two connexin hemichannels, thereby preventing the for-
mation of gap junctions [119,120]. 43Gap26 (VCYDKSFPISHVR)
and 43Gap27 (SRPTEKTIFII) do block gap junctions [119,121] but
the effect is time and concentration dependent. In most cases, a
time window can be deﬁned where hemichannels are inhibited
without concurrent effects on gap junctions. The duration of this
time window may depend on the connexin turnover rate: in most
cases 1 h exposure times have no effect on gap junctions but even 6 h
exposures have been reported not to inﬂuence gap junctions [122]. Cur-
rently, ourworking hypothesis is that 43Gap26 or 43Gap27 interactwith
unapposed hemichannels thereby inhibiting these channels, followed
by impaired docking and failure to form new gap junction channels
[123]. The effectiveness of gap junction blocking also appears to depend
on the peptide concentration. Peptides like 43Gap26 and 43Gap27 are
often used at concentrations in the range of 100 to 300 μM. ‘Peptide
5’, whichmimics a Cx43 sequence of a few amino acids inN-terminal di-
rection as compared to 43Gap27 and also contains the SRPTEK sequence
present in 43Gap27, blocks Cx43 hemichannels but does not inﬂuence
gap junctions when applied at a concentration of 5 μM even with
exposure times as long as 24 h [124]. Recent work in ischemia applied
to the brain of fetal sheep or to adult rat retina has brought up in vivo
evidence that Peptide 5 confers cellular protection by targeting Cx43
hemichannels [125,126].
Our initial studies reporting hemichannel block by connexin mi-
metic peptides were based on ATP release/dye uptake measurements
in response to [Ca2+]i elevation [35,42,123,127]. These ﬁndings were
complemented by electrophysiology studies indicating that these
peptides also inhibited depolarization-induced macroscopic currents
in Cx43 expressing taste cells [128]. More recently, we have found
that 43Gap26/27 indeed inhibits Cx43 hemichannel-mediated unitary
current activities within minutes in cell lines stably transfected with
Cx43 and in native cells endogenously expressing Cx43 at concentra-
tions in the 100–200 μM range (Wang et al., under review). In most
cases, inhibition of gap junctions is much slower, often in the range
of several hours as mentioned before [122,129].A potential tool for more selective inhibition of hemichannels
without associated inhibition of gap junctions consists of a synthetic
peptide that corresponds to the L2 sequence on the CL of Cx43 (amino
acids 119–144, further called L2 peptide) [39]. Evidence that the L2
domain is an importantmolecular determinant of Cx43 channel function
was obtained in the context of studies performed to understand
acidiﬁcation-induced closure of gap junctions. Divergent techniques in-
cluding resonance mirror spectrometry, translation diffusion analysis
and enzyme-linked sorbent assay all pointed to an increased interaction
between the L2 domain and the CT of Cx43 at low pH (~6.5) [130,131].
Over the past decade, a ‘ball-and-chain’model has been proposed to ex-
plain the Cx43 gap junction closure during acidiﬁcation: driven by the
decline of pH, the CT may move as a ﬂexible gating particle and bind to
the L2 site at the intracellular vestibule, resulting in a conﬁned channel
pore [132–135]. Interestingly, work with L2 peptide has further demon-
strated that the ball-and-chain hypothesis may also apply to the
voltage-dependent gating of Cx43 gap junction channels. In this case,
intramolecular CT–CL interaction is hypothesized to underlie the fast
gating transition from the fully open state to the sub-conductance state
[136]. L2 peptide, when delivered into the cell via awhole-cell recording
pipette, prevented the Cx43 gap junction channel residing from the open
to the sub-conductance state at high transjunctional voltage (Vj=±
60 mV) as well as slightly increased the open time. However, questions
as to howoneuniquemolecular basis accounts for two distinct gates, i.e.,
pH-dependent chemical gate versus voltage-dependent fast gate is yet
not resolved. More recently, collaborative work with the Bultynck
and Retamal groups has demonstrated that L2 peptide linked to the
TAT membrane-translocation sequence (TAT-L2) inhibits Cx43
hemichannel-related ATP release, dye uptake and macroscopic mem-
brane currents [39]. Importantly, thiswork indicated that CT–CL interac-
tion is actually necessary for hemichannel activation. Thus, preventing
CT–CL interaction with L2 peptide inhibits unapposed hemichannels
while slightly stimulates gap junctional coupling. A follow-up study in
which TAT-L2 was locally injected into the rat basolateral amygdala
demonstrated inhibition of fear memory consolidation, indicating a
role of astroglial Cx43 hemichannels in memory function [137].
Antibodies targeting the second extracellular loop of Cx43 (aa
185–206; Cx43(E2)) have also been used to block hemichannels
[44,138]. Interestingly, Cx43(E2) antibodies inhibit Cx43 hemichannel-
associated prostaglandin release in osteocytes, but leave dye coupling
and P2X7 receptor unaffected. Further electrophysiological characteriza-
tion is necessary to deﬁnewhether these antibodies block hemichannels
directly, i.e. via pore block or through modulation of channel gating.
Careful interpretation is warranted when functional roles of connexin
hemichannels are investigated with pharmacological tools. In most cases,
not only gap junctions are inﬂuenced but also Panx1 hemichannels, be it
at sometimes different concentrations [6], and several other ion channels
and transporter proteins. Panx1 hemichannel currents are rapidly
reduced by a low concentration of carbenoxolone (~5 μM) that has no ef-
fect on Cx46 connexin hemichannels [66] and showmoderate sensitivity
to ﬂufenamic acid at concentrations that inhibit connexin hemichannels
[99]. La3+ inhibits connexin hemichannels and exerts no effect on gap
junctions or Panx1 hemichannels [65]; however, this trivalent ion also in-
hibits Ca2+ channels [139,140]. Probenecid blocks Panx1 hemichannel
currents at concentrations that also inhibit organic anion transporters
(150–350 μM) [141]; however, it does not inhibit currents mediated by
Cx46 hemichannels or chimeric Cx32E143 hemichannels (the ﬁrst extra-
cellular loop of Cx32 was replaced with that of Cx43) [141]. The Panx1
mimetic peptide 10Panx1, containing a sequence on the ﬁrst extra-
cellular loop (WRQAAFVDSY), inhibits Panx1 hemichannels [65]
but apparently also inhibits Cx46 hemichannel currents in the
same concentration range (~200 μM) [142]. Additionally, Panx1
may form a complex with P2 receptors and therefore can be affected
by P2 receptor antagonists [62,65,143,144] including brilliant blue G,
pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS),
oxidized ATP and suramin [67].
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to a sequence located in the L2 domain of Cx43. This peptide inhibits
Cx43 hemichannels without inhibiting Panx1 hemichannels or gap
junctions. In exogenous Cx43 expression systems and in freshly isolated
ventricular cardiomyocytes that display strong endogenous expression
of Cx43,we demonstrated that Gap19 peptide inhibits hemichannels by
shifting the activation voltage for hemichannel opening towards more
positive potentials, without affecting the single channel conductance
(Wang et al., submitted).
4. Signaling molecules released through hemichannels
4.1. ATP
ATP efﬂux through open hemichannels is driven by a large gradient
between intracellular (several millimolar) and extracellular concentra-
tion of ATP (~10,000 fold, which is comparable in magnitude to the
Ca2+ concentration gradient but is in the inverse direction). Quantiﬁca-
tion of ATP release by bioluminescent luciferin–luciferase based assays,
demonstrated that the cellular ATP loss is limited (≤0.1% of intracellular
ATP content). Once released in the extracellular space, ATP and its
metabolites ADP, AMP and adenosine diffuse away and can bind to
purinergic receptors of the P1 (adenosine) and P2 subtypes on neighbor-
ing cells to producemetabotropic (P1 or P2Y) or ionotropic (P2X) down-
stream responses [145,146].
4.1.1. ATP release in the context of intercellular calcium waves
Signiﬁcant evidence is available demonstrating connexin hemi-
channel involvement in ATP release as a paracrine pathway for the
propagation of intercellular Ca2+ waves. Intercellular Ca2+ waves
are cell-to-cell propagating [Ca2+]i changes that were initially
reported to be mediated by the diffusion of the Ca2+ mobilizing mes-
senger inositol 1,4,5-trisphosphate (IP3) via gap junctions [147–149].
The contribution of paracrine signaling was suggested later by the
ﬁnding that focally triggered intercellular Ca2+ waves could spread
to cells separated from the trigger zone by a cell-free region [150].
Medium collected from cell cultures displaying intercellular Ca2+
waves contains ATP and is capable of initiating intercellular Ca2+
waves when applied to non-stimulated cultures [151]. Blockage of
purinergic receptors or degradation of ATP suppresses the spread of
intercellular Ca2+ waves, supporting a contribution of ATP-mediated
purinergic signaling in this process. Extracellular ATP-mediated propa-
gation of intercellular Ca2+ waves have been established in various cell
types ranging from glial cells to keratinocytes (reviewed in [152]). The
linkage of ATP release to connexin hemichannels was based on the ob-
servation of a close correlation of the size of intercellular Ca2+ waves
with the level of connexin expression [153], which was caused by in-
creased connexin-related ATP release rather than augmented gap junc-
tion coupling [33]. However, connexin hemichannels are not the only
pathway of ATP release involved in intercellular Ca2+ waves and
there is evidence for vesicular release as well [154]. The trigger for
hemichannel opening appears to be IP3 [127] and subsequent [Ca2+]i
changes [34,35]. If connexin hemichannels are involved, the waves are
often larger under conditions of low extracellular Ca2+ or in the pres-
ence of quinine which both promote connexin hemichannel opening
[45,155]. Interestingly, not only the size but also the frequency of spon-
taneously occurring intercellular Ca2+ waves is increased by lowering
extracellular Ca2+ [45,156,157], an effect that may result from in-
creased connexin hemichannel opening and ATP release [158]. Biolumi-
nescent ATP imaging has indicated that under low extracellular Ca2+
conditions, intercellular Ca2+ waves are associated with ATP release
from a single cell. A burst of ATP from a single-cell has been conclud-
ed from the fact that only one cell of all the cells contributing to the
wave displayed uptake of the ﬂuorescent hemichannel-permeable
dye propidium iodide [158]. These observations have been con-
ﬁrmed in another study [159].An interesting approach toward inﬂuencing connexin channels in-
volved in intercellular Ca2+ waves consists in the use of connexin
targeting peptides. Short incubations with connexin mimetic pep-
tides (Gap26 or Gap27) partly inhibit IP3-triggered intercellular
Ca2+ waves, by inhibiting hemichannel ATP [127] while longer appli-
cations (>1 h pre-incubation) more strongly inhibit the waves be-
cause of combined inhibition of hemichannels and gap junctions.
Application of TAT-L2 peptide also partly inhibits intercellular Ca2+
wave propagation because of more selective hemichannel suppres-
sion without inﬂuencing gap junction channels [39].
Evidence for a contribution of hemichannel ATP release is also
available from brain slices, retina and the organ of Corti in the inner
ear. ATP release in embryonic slices from neocortex was assessed
using GL261 glioma cells as biosensors that display [Ca2+]i changes
in response to ATP [37]. Spontaneous Ca2+ waves and oscillations in
neural precursor cells were associated with ATP release and both re-
sponses were inhibited by carbenoxolone (100 μM) and Cx43 silenc-
ing. A similar biosensor ‘sniffer cell’ approach has been used in
neonatal brain slices to document ATP release associated with
intercellular Ca2+ waves triggered by electrical stimulation [160];
however, connexin hemichannels did not appear to be involved in
this study. By contrast, recent work in neonatal hippocampal slices
has brought up clear evidence for hemichannel opening and subse-
quent ATP release [161]. A local decrease of [Ca2+]o, brought about
by photoactivation of the Ca2+ buffer diazo-2, was used to trigger
hemichannel opening and this triggered a slowly propagating (4 μm/s)
intercellular Ca2+ wave in astrocytes. Imaging of extracellular ATP
making use of luciferin–luciferase in combination with a low noise/
highly sensitive CCD camera demonstrated a ‘cloud’ of ATP that
also expanded in a wave-like manner as a function of time. The ATP
release and Ca2+ wave were strongly reduced in Cx30/Cx43 deﬁ-
cient mice. This paper furthermore added evidence that increased
neuronal activity is associated with a decrease in [Ca2+]o, which is
sufﬁcient to trigger hemichannel opening and ATP release from as-
trocytes. Importantly, the authors demonstrated that the released
ATP activated inhibitory interneurons thereby providing negative
feedback to the initially active neuron [161].
In the retina, stimulated intercellular Ca2+waves propagate through
glial cells that consist of both astrocytes andMüller cells [162]. InMüller
cells, the waves strongly rely on paracrine purinergic communication
and the retinal Ca2+ wave is associated with a wave of extracellular
ATP increase [162]. Intercellular Ca2+ waves in retinal glial cells also
occur spontaneously, both in vitro and in vivo, and the Ca2+ waves are
associated with an extracellular ATP wave [163]. The evidence pointing
to connexin hemichannels as the ATP release pathway in Müller cells
is based on their abundant Cx43 expression, inhibition of ATP release
by 100 μM carbenoxolone (but not 5 μM that only blocks Panx1
hemichannels) and insensitivity to inhibitors of CFTR or
P-glycoprotein transporters [164]. In embryonic pigment epithelial
cells, Cx43 hemichannels activated by spontaneous intracellular
Ca2+ transients release ATP, as evidenced from work with short ap-
plication of 43Gap26 (30 min) [159].
In organotypic cultures of the organ of Corti, intercellular Ca2+ waves
triggered by various stimuli and propagating between supporting cells,
were associated with ATP release as measured with biosensor cells
[117]. The waves were dependent on Cx26 and Cx30 expression but not
on the expression of Panx1 or P2X7, and were inhibited by La3+; collec-
tively, these data indicate a contribution of connexin hemichannels to
ATP release in these cells [38,117].
It is important to realize that ATP release via connexin
hemichannels is not an isolated process. First of all, a mechanism of
ATP-induced ATP release may act to amplify the ATP release [165].
This process involved activation of low afﬁnity P2 receptors, which
may well be P2X7 receptors that are coupled to Panx1 hemichannels
opening [65,166]. Second, because ATP can be released from cells by
diverse pathways, it is possible that an initial hemichannel-related
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lease pathways.
What is the function of hemichannel ATP release associated with
intercellular Ca2+ waves? Some suggested functions will be
discussed next but it is important to start with some remarks that
may help to put this information in the correct context. First, ATP re-
lease and paracrine purinergic communication is just one aspect of
intercellular Ca2+ waves. Several of the effects may well be the con-
sequence of the associated [Ca2+]i changes or of a combination of
[Ca2+]i dynamics and ATP release. Second, and this also holds true
for proposed functions of other paracrine messenger released
via hemichannels, there is up to now no evidence available that sup-
ports a complete paracrine signaling cascade that starts with the
hemichannel release process, continues with actions on speciﬁc
membrane receptors and culminates in clear, fully documented func-
tional responses (preferably recorded in vivo). Obviously, the major
problem here is the fact that the currently available tools and technol-
ogy (KO and transgenic approaches) in most cases inﬂuence both gap
junctions and hemichannels. Limited tools are becoming available
however, as discussed above, and it is anticipated that this will
bring up novel insights.
Extracellular ATP-mediated intercellular Ca2+ waves coordinate
[Ca2+]i signaling within a group of neighboring cells, synchronizing
different phases of cell cycles including resumed proliferation of rest-
ing cells, DNA synthesis and mitosis [167,168].
In the brain, during neocortical development, radial glial cells dis-
play intercellular Ca2+ waves that appear to be initiated by connexin
hemichannel ATP release and that are involved in radial glia cell pro-
liferation in the ventricular zone [157]. Here, as in other organs and
tissues, ATP is proposed to act as a mitogenic signal that acts to syn-
chronize cell cycles of a population of cells thereby coordinating pro-
liferation in the ventricular zone [37]. As already referred to above,
evidence has recently become available demonstrating astrocyte
hemichannel opening and ATP release in response to neuronal activ-
ity. The ATP then activates interneurons thereby providing negative
feedback [161]. Presumably, this neuron–astrocyte–neuron loop acts
in parallel to the well documented direct activation of interneurons
by an axon collateral.
In the retina, ATP release from pigment epithelial cells via
hemichannels may act as a mitogenic signal to neural progenitor cells
in the ventricular zone thereby controlling their proliferation and differ-
entiation [36,159]. It has furthermore been suggested that this Ca2+
wave-associated ATP release maintains Rho-GTPase activity in neural
progenitors which is a critical modulator of cytoskeleton-directed nu-
clear mobility during mitotic division [37].
In the cochlea, a structure of the inner ear, the evidence for
hemichannels in ATP release and possible functional consequences
is more extensive and for this reason, this subject will be discussed
in a separate section that follows.
4.1.2. ATP release in the cochlea
Cx26 and Cx30 are most predominantly expressed in the cochlea
supporting and epithelial cells, but are absent in the auditory sensory
hair cells [169]. Animals with defective expression of Cx26/Cx30 in
inner ear exhibit signiﬁcant hearing loss. A great number of mutations
in Cx26 and Cx30 have been identiﬁed in syndromic and nonsyndromic
deafness. Functional assessments of Cx26/Cx30 in the cochlea point out
that these two connexins can regulate auditory development and trans-
duction in a paracrine manner through formation of connexin
hemichannels.
Before the cochlea reaches maturity to convert sound into electri-
cal signals in the auditory nerve ﬁbers [170], sound-independent ex-
citation of auditory nerves is required to ﬁne tune the tonotopic map
for optimal sound perception. In the developing cochlea, supporting
cells in Köllicker's organ, a transient structure in the organ of Corti
located adjacent to the sensory hair cells, spontaneously release ATPthat acts on purinergic receptors on inner hair cells [171]. As already
discussed before (Section 4.1.1), there are several arguments pointing
to connexin hemichannels as a likely release conduit. The released
ATP has been demonstrated to trigger Ca2+ spikes in inner hair
cells, triggering bursts of action potentials in the spiral ganglion neu-
rons [171]. In this way, spontaneous activation of spiral ganglion neu-
rons maintains survival of neurons in the cochlea nucleus and
optimizes the spatial organization of auditory pathways during
development.
In themature cochlea, evidence from two different labs has demon-
strated a unique distribution pattern that Cx26 is colocalized with Cx30
in the cochlear supporting and epithelial cells [172,173], indicating that
these two proteins favor co-assembly into heteromeric hemichannels.
Various physiological factors including sound-induced mechanical
stimulation in the form of basilar membrane vibration, typically low
[Ca2+]o (~20 μM) and high extracellular K+ levels ([K+]o≈150 mM)
in the endolymph are known as potent modulators of connexin
hemichannels. Most of these stimuli (mechanical stimulation and low
[Ca2+]o) have been found to trigger ATP release in vitro, and these re-
sponses are inhibited by connexin channel blockers but not by
inhibiting vesicular ATP release or ATP-binding cassette transporters
[174]. Taken together, it is thus plausible that ATP is released through
heteromeric Cx26/30 hemichannels. The released ATP may act on
outer hair cells, by binding to P2X receptors, which results in a de-
creased electromotility of these cells. Outer hair cells function as an ac-
tive cochlear ampliﬁer that promotes the vibrations of the basilar
membrane. Thus, because ATP reduces the electromotility of outer
hair cells, this will result in a decreased ampliﬁer gain and hearing
sensitivity.
4.1.3. ATP release in taste transduction
In taste buds, the signal transduction from taste cells to afferent
nerve ﬁbers appears to be more complex than initially thought.
Serotonin (5-hydroxytryptamine (5-HT)) has long been considered
as the major neurotransmitter between taste cells and gustatory
nerve ﬁbers. It was later discovered in a 5-HT3A KO animal model
that preventing 5-HT signaling did not alter taste perception,
suggesting an additional afferent neurotransmitter active in the
taste transduction [175]. ATP became a plausible candidate because
of the presence of P2X2/P2X3 receptors in the afferent nerve ending
and this was soon conﬁrmed by work in P2X2/P2X3 double KO mice
[175]. Interestingly, the ATP releasing cells in the taste bud have
been identiﬁed as Type II receptor cells which sense bitter, sweet,
and umami compounds through activation of G-protein coupled
taste receptors [176]. Of equal interest is the fact that these cells
lack the vesicular machinery for the classic exocytotic release of neu-
rotransmitters [177]. Further attempts to characterize the molecular
basis of the release pathway revealed that ATP release in the receptor
cells was driven by repetitive depolarization pulses, as would occur
by generator potentials in activated taste cells, and was not depen-
dent on [Ca2+]i changes by Ca2+ inﬂux [176]. The connexin mimetic
peptide 43Gap26 (5–15 min) abolished the ATP release in receptor
cells while 32Gap27 exerted no effect. Electrophysiological recordings
deﬁned a voltage-dependent, 43Gap26-sensitive current whose mag-
nitude was correlated with the intensity of the ATP release [128]. Low
concentrations of carbenoxolone (5 μM, 30 min) had little effect
suggesting no contribution of Panx1 hemichannels. However, others
have reported that low carbenoxolone concentrations do inhibit ATP
release and signal transduction pointing to Panx1 hemichannels
[178]. ATP released from receptor cells in response to TRPM5
channel-mediated depolarization with concurrent [Ca2+]i elevation
[179] may directly activate receptors on the afferent nerve ending,
but may also stimulate adjacent presynaptic cells to secrete 5-HT
[178]. Taken together, these observations suggest that both Cx43
and Panx1 hemichannels may play a role in taste cell signaling.
Fig. 3 summarizes the currently available evidence supporting a role
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perhaps one of the few covering a more complete paracrine signaling
cascade with both hemichannel source and functional consequences
being characterized. However, further work is still needed to delin-
eate the distinct contribution of Cx43 and Panx1 hemichannels. The
involvement of pannexins in ATP release is further considered in
more detail in Section 4.1.6.4.1.4. ATP release inﬂuencing cell death/cell survival in disease
Abnormal connexin hemichannel-mediated paracrine signaling
has been implicated in a genetic disorder termed hidrotic ectodermal
dysplasia [180]. Disease-associated Cx30 mutants (G11R and A88V)
form normal gap junctions but defective hemichannels. Uncontrolled
ATP efﬂux through these leaky channels may enhance the prolifera-
tion and differentiation of keratinocytes through purinergic signaling
[181], giving rise to a severe skin phenotype. Similarly, leaky
hemichannels composed of mutated Cx32 (F235C) have been pro-
posed to contribute as a mechanism of cellular toxicity in the
X-linked Charcot–Marie–Tooth disease, a demyelinating disorder
[182]. It is not known here whether hemichannel ATP release contrib-
utes to the presumed toxicity.
Mechanical damage or ototoxic drugs may facilitate hemichannel
ATP release from supporting cells in the organ of Corti and may act
as a cell death signal via activation of P2 receptors [183]. This triggers
an intercellular Ca2+ wave that activates ERK1/2 in supporting cells,
which is associated with increased hair cell death.Fig. 3. Role of Cx43 and Panx1 hemichannels in paracrine signaling in taste transduction. In t
located at the apical membrane of type II receptor cells. Activation of the GPCR signaling path
(PLCβ)-mediated cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2). An increase of
subfamily M member 5 (TRPM5). Na+ inﬂux through TRPM5 channels depolarizes the cel
an action potential (AP). Available evidence indicates that in response to tastent-evoked me
cellular ATP is thought to function as a neurotransmitter, targeting P2X2/P2X3R at postsynap
aptic type III receptor cells. Following elevation of [Ca2+]i by IP3, a second taste transmitterConnexin hemichannel-dependent ATP release appears to be in-
volved in cell protection in the context of ischemic preconditioning,
a process that activates protective signaling cascades in response to
repeated episodes of subletal ischemia. Hypoxic preconditioning in-
duced by low concentration of H2O2 or tamoxifen in cultured astro-
cytes increases the density of membrane surface Cx43 hemichannels
as a consequence of impaired Cx43 degradation [184]. ATP release
mediated via the expanded pool of Cx43 hemichannels leads to an en-
hanced accumulation of itsmetabolite adenosine. Adenosine is a general
inhibitor of neurotransmissionwith neuroprotective effect on theneural
tissue [185]. The ischemic preconditioning effect disappears with Cx43
silencing or connexin channel blockers [184]. Additionally, conditional
Cx43 KO in astrocytes removes the protective preconditioning effect in
mice subjected to occlusion of the middle cerebral artery. Along the
same line, ATP release through Cx36 hemichannels has been implicated
to increase the tolerance against ischemia provided by cortical spreading
depression [186]. Cortical spreading depression denotes the waves of
depolarization that spread over the brain cortex in response to focal in-
jury or application of a high K+ solution on thebrain surface. Application
of high K+ solution to primary cultures of cortical neurons triggers
membrane depolarization and release of ATP, which acts, in a paracrine
manner, on P2Y receptors and protects neurons against in vitro applied
ischemic conditions via PLC and PKA-dependent signaling. The evidence
pointing to hemichannels as the ATP release pathway were based on
work with connexin channel blockers and Cx36 silencing.
Connexin hemichannel ATP release has also been implicated in is-
chemic preconditioning in the heart. It is known that mitochondrialaste buds, G-protein coupled receptors (GPCRs) for bitter, sweet and umami tastents are
way leads to the production of IP3 and diacyl glycerol (DAG) through phospholipase Cβ
[Ca2+]i by IP3-induced Ca2+ release opens transient receptor potential cation channel
l membrane and stimulates voltage-gated Na+ channels, promoting the generation of
mbrane depolarization, Cx43/Panx1 hemichannels open, facilitating ATP release. Extra-
tic afferent nerves. Alternatively, ATP may diffuse and bind to P2YR at adjacent presyn-
5-HT is secreted from the presynaptic cells through vesicular release.
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Recent work has indicated that opening of mitochondrial Cx43
hemichannels may be involved in the complex cascade leading to pro-
tection [189]. It is hypothesized that preconditioning leads to opening
of Cx43 hemichannels in the innermitochondrial membrane, with sub-
sequent loss of ATP from the mitochondrial matrix. This activates
ATP-dependent K+ channels that appear to be central in the protective
effect.
4.1.5. ATP and immune cell responses
During hypoxia or acute inﬂammation, increased connexin
hemichannel activity in polymorphonuclear leukocytes (PMNs) di-
rectly correlates with elevated vascular nucleotides including ATP,
ADP and AMP [190]. PMNs activated by hypoxia/inﬂammation dis-
play ATP release that is inhibited by 43Gap27 (but not 40Gap27
targeting Cx40) and not affected by inhibiting the secretion of granular
vesicles, nucleoside transporters or transporters from the ATP binding
cassette family. PMNs isolated from mice with induced Cx43 deletion
had signiﬁcantly decreased ATP release, pointing to a contribution of
Cx43 hemichannels. It is conceivable that Cx43 hemichannel opening
is mediated by dephosophorylation at S368 in a phosphatase
2A-dependent signaling pathway [190,191]. It is hypothesized that
the ATP released by PMNs is metabolized to AMP by CD39 present
at the PMN surface [190] and subsequently converted to adenosine
by endothelially located CD73 [192]. Adenosine then activates endothe-
lial A2B receptors [193], leading to downstream cAMP/PKA pathway
that inactivates the endothelial cell contraction and enhances the
cell-matrix adhesion complex [194], thus self-limiting the disrupted
vascular barrier due to PMN migration. Hypoxia upregulates the ex-
pression of CD39, CD73 and A2B receptor, further amplifying the inter-
play of PMNs with endothelial cells. It was later suggested that Cx43
hemichannels in vascular endothelia can additionally contribute to ac-
cumulation of extracellular ATP [195]. However hypoxia reduces the
ATP release from endothelial cells, making such contribution less likely.
Evidence is also available for bacillar dysentery caused by Shigella
ﬂexneri: invasion of the colonic mucosa with this bacteria triggers
inﬂammation and subsequent destruction of the epithelium. During
the process of invasion, the dispersion of bacteria from the infection
zone to neighboring regions is modulated by ATP release through
connexin hemichannels. Evidence for this came from the ﬁnding
that HeLa cells exogenously expressing human Cx26 (hCx26) showed
a larger degree of Shigella invasion and spreading than wild-type cells
[196]. hCx26 hemichannel opening in infectedHela cells were indicated
by uptake of Lucifer yellow and explained by Shigella-triggered
cytoskeleton-reorganization and PLC activation. Released ATP activates
purinergic receptors on neighboring cells, triggering [Ca2+]i changes
which promote Shigella entry and further bacterial spreading.
4.1.6. ATP and immune effects of pannexin hemichannels
KO of major connexins like Cx26 or Cx43 results in embryonic le-
thality [197,198] or perinatal death [199]. By contrast, KO of Panx1
gives an apparently normal phenotype [5]. However, there is a sig-
niﬁcant amount of data available that suggest roles of Panx1
hemichannels. Hemichannel related ATP release was ﬁrst reported
in Panx1 expressing oocytes [62] and supported by follow-up studies
performed in erythrocytes that lack connexin expression [200].
Erythrocytes display single-channel events with unitary conduc-
tance of ~450 pS that are activated by depolarization and
mechanostimulation. The mechanosensitivity of these channels
[63] makes it likely that shear stress, caused by the blood ﬂow, stim-
ulates Panx1 hemichannel opening. Released ATP binds to P2Y re-
ceptors on neighboring endothelial cells, generating intercellular
Ca2+ waves that lead to the generation of nitric oxide that acts as a
vasodilator on smooth muscle cells [201,202]. Released ATP may
also activate P2X7 receptors in an autocrine and paracrine manner
[203], resulting in the release of cis- and trans-epoxyeicosatrienoicacids from erythrocytes, that act as vasotropic agents controlling
the local blood ﬂow.
The P2X7–Panx1 hemichannel complex has been implicated in
the release of interleukin-1β from macrophages [65]. However, this
ﬁnding has been challenged by the fact that bone marrow-derived
macrophages isolated from Panx1-deﬁcient animals are still capable
of secreting pro-inﬂammatory cytokines upon activation [100]. Sim-
ilarly, interleukin-1β release in glial cells is explained by a Panx1
hemichannel-independent mechanism [204]. P2X7 stimulation in
astrocytes activates acid sphingomyelinase through a p38 MAPK sig-
naling cascade, leading to interleukin-1β release as microparticles.
Recent evidence points to an important contribution of ATP/UTP
release via Panx1 hemichannels that acts as a ‘ﬁnd-me’ signal that
recruits phagocytes to clear cells undergoing apoptosis [72,100]. As
speciﬁed in Section 2.5, Panx1 hemichannels are activated during
apoptosis by caspase cleavage of the CT tail.
4.2. NAD+
The metabolic substance NAD+ has long been known to be
converted to cyclic ADP-ribose (cADPR) by CD38, a transmembrane
enzyme with the catalytic domain facing the extracellular side
(ectoenzyme). cADPR imported into the cell via CD38 or a family of
nucleoside transporters activates type 2 and type 3 ryanodine recep-
tors at the endoplasmic/sarcoplasmic reticulum, resulting in the re-
lease of Ca2+ [205]. It was however less clear how NAD+ could
reach the catalytic site of CD38. Work with unilamellar liposomes
with reconstituted puriﬁed Cx43 proteins has brought up the possi-
bility that Cx43 hemichannels may act as a diffusive conduit for
NAD+ [206]. This concept was further validated by the demonstration
that Cx43 silencing completely prevented transmembrane efﬂux of
NAD+ in 3T3 ﬁbroblasts [206]. Using the same cells, it was further-
more shown that NAD+, released from cells transfected with CD38
(CD38+), were able to induce [Ca2+]i elevation in surrounding cells
lacking CD38 (CD38−) via cADPR action [207], while monocultures
of CD38− cells were not responsive. The [Ca2+]i stimulation of
CD38− by CD38+ cells disappeared in the presence of a connexin
channel inhibitor and by silencing Cx43 in the CD38+ cells. This
Cx43 hemichannel related NAD+-mediated paracrine Ca2+ signaling
promoted 3T3 ﬁbroblast proliferation with shortened S phase of the
cell cycle [207]. A similar effect was found in human hemopoietic pro-
genitors when co-cultured with murine stroma cells overexpressing
CD38+ [208]. NAD+ release via Cx43 hemichannels may also be in-
volved in mucosal cells; its conversion to cADPR appears to potentiate
the contractility of tracheal smooth muscle cells [209].
4.3. Glutamate
Glutamate is a major excitatory neurotransmitter, not only between
neurons but also involved in the neuron-glial signaling network [210].
Astrocytes clear extracellular glutamate via glutamate uptake through
GLAST and GLT-1 transporters [211]. However, under pathological
conditions such as ischemia or inﬂammation, astrocytes may actually
contribute to glutamate release [212], leading to overstimulation of
postsynaptic glutamate receptors and neuronal death [213]. In addition
to well-deﬁned glutamate release pathways such as glutamate trans-
porters acting in reversed mode and volume-regulated anion channels,
connexin hemichannels in astrocytes have been suggested as another
favorable candidate. In cultured astrocytes, the presence of unapposed
hemichannels was indicated by a unique distribution of Cx43 in the
non-junctional membrane and dye uptake triggered by depletion of
extracellular Ca2+ [214]. Extracellular Ca2+ depletion also triggered
glutamate release, whichwas independent of [Ca2+]i changes, abrogat-
ed by several connexin channel blockers, and insensitive to agents
inhibiting glutamate transporters or anion channels [214]. Further evi-
dence has implicated Cx43 hemichannels in hyperosmolarity-induced
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based on rapid inhibition by 43Gap26 and absence of effects of interfering
with glutamate transporters, anion channels, Panx1 hemichannels and
P2X7 receptors.
In addition to astrocytes, microglial cells may also display
connexin hemichannel-mediated glutamate release [217]. Microglia
activated by pro-inﬂammatory agents produces tumor necrosis
factor-α, which upregulates intracellular glutamate synthesis via
glutaminase-involved autocrine mechanism and promotes gluta-
mate release. Elevated glutamate level in the extracellular matrix
leads to neuronal cell death by activating NMDA receptors, inhibiting
mitochondrial respiration and depleting intracellular ATP. Gluta-
mate transport as well as the subsequent neurotoxicity can be
suppressed by 32Gap27 but not by 43Gap27, indicating a Cx32
hemichannel-governed release mechanism. Inﬂammation-stimulated
macrophages seem to cause neurotoxicity in a similar manner [218].
The possible contribution of connexin hemichannels in glutamate
release has inspired further work towards the molecular mechanism
underlying neurodegeneration in Alzheimer's disease. Amyloid-β acti-
vates Cx43 hemichannel openings in both microglial cells and astro-
cytes [219]. Cytokines secreted by activated microglia may further
enhance Cx43 hemichannel activities in astrocytes [78], which pro-
motes the release of glutamate and leads to neuronal cell death.
4.4. Glutathione
During oxidative stress, glutathione can function as an electron
donor for the clearance of peroxide [220]. Astrocytes may contribute
to neuroprotective effects via glutathione-mediated metabolic interac-
tions with neurons [221]. Astrocytes can release glutathione, which is
converted into cysteinylglycine by astrocyticγ-glutamyl transpeptidase
[222]. Subsequently, cysteinylglycine is catalyzed by γ-glutamyl
transpeptidase resulting in cysteine and glycine [223]. Increased extra-
cellular cysteine potentiates its neuronal uptake and intracellular pro-
duction of glutathione. Astrocytic glutathione release is stimulated by
depletion of extracellular Ca2+ level, inhibited by connexin channel
blockers and not affected by P2X7 receptor antagonist, thereby sharing
a similar pharmacological proﬁle with connexin hemichannels [224].
The involvement of hemichannels is also suggested by a study investi-
gating the effect of curcumin on glutathione efﬂux from astrocytes
[225]. Curcumin, a compound found in popular Indian spice,
upregulates the synthesis of glutathione in astrocytes by stimulating
transcriptional genes responsible for astrocytic antioxidant defense.
The enhanced glutathione production results in increased efﬂux that
is reduced by 43Gap26 and not inﬂuenced by P2X7 receptor inhibition
or 10Panx1 peptide. In hippocampal slices, the pharmacological proper-
ties of the glutathione efﬂux triggered by removal of extracellular Ca2+
are identical to those reported in the cell culture systems [226].
4.5. Prostaglandin E2
Mechanical forces regulate a continuous process of bone remodel-
ing. Osteocytes embedded in the bone tissue are endowed with a
mechanosensory function, transducingmechanical signals to neighbor-
ing osteocytes and cells on the bone cell surface including osteoblasts,
osteoclasts and bone-lining cells through both gap junction coupling
and paracrine intercellular communication [44]. Prostaglandin E2, iden-
tiﬁed as one of the paracrine messengers released by osteocytes, stim-
ulates bone formation via its actions on osteoblasts. At high
concentrations and long exposure times, prostaglandin E2 induces
bone resorption by enhancing osteoclast formation and activation.
Bone remodeling is modulated by a well balanced process of
bone-resorption and formation. Themarked expression of Cx43 in oste-
ocytes together with the fact that Cx43 hemichannels can be activated
by mechanical stimuli has led to the hypothesis that these cells release
prostaglandin E2 via the hemichannel pathway. Fluid ﬂow shear stressresembling the natural mechanical forces-induced interstitial ﬂuid
ﬂow [227], has been demonstrated to trigger prostaglandin E2 release
from osteocyte-like MLO-Y4 cells in low-density cultures devoid of
gap junctions [49,228]. The presence of Cx43 hemichannels at the cell
surface was conﬁrmed by biotinylation and cellular dye uptake studies
[49]. Shear stress-induced increase of extracellular prostaglandin E2 is
inhibited by Cx43 silencing and carbenoxolone, but not by inhibitors
of P2X7 receptors or prostaglandin transporters. It appears that
mechanostimulation of Cx43 hemichannels are endowed with an inac-
tivationmechanism that limits prostaglandin release: short exposure of
osteocytes to ﬂuid ﬂow shear stress (30 min) increases Cx43
hemichannels openings, but leaves the density of the hemichannels at
cell surface unaffected. Longer stimulation (2 h) results in increased
prostaglandin release as a result of increased density ofCx43
hemichannels in the plasmamembrane. Sustained periods of mechani-
cal stimulation (4 h) closes the hemichannels and if the exposure to
mechanical stress is further increased (24 h), the plasma membrane
density Cx43 hemichannels is downregulated. This adaptive regulation
of Cx43 hemichannels prevent overstimulation of osteoclasts by
uncontrolled elevation of extracellular prostaglandin E2 and therefore
avoid bone loss.
5. Conclusion
Numerous reported data demonstrate that hemichannels may func-
tion as a release pathway for paracrine messengers. This includes data
showing hemichannel-mediated release of ATP, prostaglandins and
other compounds (Table 1) in cells expressing Cx26, Cx32, Cx36, Cx43
and Panx1. However, paracrine signaling involves more than just
release of a messenger. At present, there is not enough data to draw a
complete signaling cascade that starts with hemichannel-mediated
messenger release and its speciﬁc triggers, and ends with the target
receptors and consequent functional alterations. The reason for this
relates to the difﬁculty of separating the functions of connexin
hemichannels from gap junctions composed of the same connexins
and, along the same line, distinguishing connexin from pannexin
hemichannels. Thus, new tools are urgently needed to overcome this
fundamental gap in the connexin/pannexin channel ﬁeld. The tools
needed include novel concepts that can be used for the design of new
pharmacological agents and for the design of transgenic approaches to
disentangle the connexin and pannexin signaling network. A second
reason relates to themaster paracrine signalingmolecule ATP: this sub-
stance has numerous release mechanisms including the diffusive re-
lease via plasma membrane channels (hemichannels, maxi-anion
channels), carrier-facilitated release and vesicular release, making it
very difﬁcult to deﬁne the exact contribution of hemichannels in ATP
release. Hemichannels may have the advantage that they provide a
high-capacity and fast release pathway [229], although the process of
openingmay be slower. However, strong claims that only hemichannels
contribute to the observed responses without contribution of other re-
lease mechanisms are currently not possible. At the receptor side, things
are also complicated: the purinergic receptor family is extensive and
lacks inhibitors with enough speciﬁcity to allow clear conclusions on
downstream functional responses. However, the good news also comes
from this side: ATP, as a paracrine messenger, has such a wide variety
of targets and proposed functions that, if hemichannels prove to be an
important pathway for its release, the consequences will be signiﬁcant.
This is related to the fact that modulation (inhibition/stimulation) at
the level of the source is expected to have stronger functional impact
(good as well as bad) than at the target. A third reason why the case
for hemichannels in paracrine signaling is still at the weak side relates
to the paucity of in vivo data. In this respect, blood cells offer interesting
opportunities because of their accessibility and the absence of gap junc-
tions when cells are separated. In conclusion, further efforts toward bet-
ter deﬁning the role of hemichannels in paracrine signaling should be
based on advantaged methodological approaches, new and more
47N. Wang et al. / Biochimica et Biophysica Acta 1828 (2013) 35–50selective tools to manipulate hemichannel function and focusing more
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